R E T R A C T E D

The emerging field of tissue engineering promises to deliver improvements in the technologies and therapies for musculoskeletal disorders through the development of biological substitutes for tissue replacement. The creation of functional tissue addresses very complex biological problems, comprising a wide range of engineering, science and clinical disciplines. The next generation of engineered musculoskeletal tissues will be more complex and structurally organized to better mimic normal tissue structure and function. Tissue engineering as an interdisciplinary approach utilizes specific combinations of cells, scaffolds and bioactive factors to create, influence and maintain cellular phenotype and function
. [4] . The promise of tissue engineering is perhaps most relevant to chondrogenic defects because cartilage has little self-healing potential.
Cartilage as a unique avascular, aneural and alymphatic loadbearing live tissue is unique in that the extracellular matrix is composed of a complex combination of type II collagen fibrils which are specifically arranged and have bonded to them by very large water-retaining molecules called aggrecan molecules
Recently, the successful isolation of human stem cells from bone marrow (BM), periosteum and other newer sources was established by different groups [5] [6] [7] [8] [9, 10] .
Although BM has been the main source for the isolation of multipotent MSCs and BM-MSCs are well characterized and safe in handling, the harvest of BM is a highly invasive procedure and the number, differentiation potential, and maximal life span of MSCs from BM decline with increasing age [11] [12] [13] . Therefore, alternative sources from which to isolate MSCs are subject to intensive investigation.
As one alternative source umbilical cord blood (UCB) has proven to offer excellent potential for clinical scale allogenic transplantation. UCB can be obtained by a less invasive method, without harm for the mother or the infant [14, 15] [17] [18] [19] or have demonstrated a low frequency of mesenchymal progenitors [20, 21] . [34] . In addition to ILK, integrin cytoplasmic domain-associated protein 1 (ICAP1) interacts with the cytoplasmic domain of ␤1 integrin [35] . CD47 or integrinassociated protein (IAP) is a membrane protein that is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix [36] .
As 
Collection of UCB
UCB units (n ϭ 59) were collected as previously described from the unborn placenta of full-term deliveries in a multiple bag system containing 17 ml of citrate phosphate dextrose buffer (Cord Blood Collection System; Eltest, Bonn, Germany) [22, 37] and processed within 24 hrs of collection.
The collection was performed in accordance with the ethical standards of the local ethical committee. 
Isolation and culture of MNC from UCB
Results
Microarray analysis
In MSC from bone marrow (BM-MSC, Table 2 , Fig. 1 (Fig. 3, Table 4 ). [41] . In addition, it has been concluded that the osteopontin receptor might be involved in processes of cellular migration and proliferation, especially in smooth muscle cells during vascular trauma [42] . Furthermore, this receptor might assist in the cellular differentiation in vitro [43] . 
Immunohistochemistry
The analysis of integrin-expression on protein-level was analysed with monoclonal antibodys against integrin ␣v, integrin ␤1, integrin ␤5, CD47 and the integrin-linked kinase (ILK). For all markers, during the whole process of chondrogenic differentiation, a constant expression for all markers could be found
Discussion
Fig. 1 Expression levels of genes for different integrins and integrin-associated proteins in MSC by microarray hybridization analysis. Results from mesenchymal stem cells from bone marrow (BM-MSC) during chondrogenic differentiation for the given genes in undifferentiated MSCs (white bars) and chondrocytes differentiated from the MSCs (black bars
Conclusion
In the present study, we analysed expression patterns of integrins and integrin-related signalling-proteins. One of the 
Fig. 2 Expression levels of genes for different integrins and integrin-associated proteins in MSC by microarray hybridization analysis. Results from mesenchymal stem cells from cord blood (CB-MSC) during chondrogenic differentiation for the given genes in undifferentiated MSCs (white bars) and chondrocytes differentiated from the MSCs (black bars
